Demplatin pegraglumer Recruiting Phase 2 Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03771820Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen